Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
47%
Obstructive Sleep Apnea
39%
Lung
33%
Non Small Cell Lung Cancer
31%
Atmospheric Aerosol
23%
Particular Matter 2.5
23%
Lung Cancer
20%
K-Complex
18%
Emphysema
18%
Tuberculosis
17%
Asthma
16%
Epidermal Growth Factor Receptor
15%
Heart Rate Variability
11%
Neoplasm
10%
Diagnostic Accuracy
10%
Chemotherapy
10%
Bronchoscopy
9%
Inflammation
9%
Oxygen Desaturation
9%
Malignant Neoplasm
9%
Diseases
8%
Endobronchial Ultrasonography
8%
Meta-Analysis
8%
Macrophage
7%
Odds Ratio
7%
Lung Tuberculosis
7%
Apnea
6%
Hypopnea
6%
Lung Adenocarcinoma
6%
Continuous Positive Airway Pressure
6%
Body Fat
6%
Blood Pressure
6%
In Vitro
6%
Biological Marker
6%
Pleura Effusion
6%
Polysomnography
6%
Climatic Change
5%
Climate Change
5%
Fine Particulate Matter
5%
Pneumonia
5%
Tyrosine-Kinase Inhibitor
5%
Sleep Disorder
5%
Angiogenesis
5%
Oximetry
5%
Forced Expiratory Volume
5%
Cohort Analysis
5%
Cancer Therapy
5%
Transbronchial Aspiration
5%
Immunology and Microbiology
Lung
100%
Particulate Matter
20%
Asthma
20%
Airway
18%
Neutrophil
17%
Inflammation
17%
T Cell
15%
Phosphotransferase
12%
Kinase
12%
Macrophage
11%
Peripheral Blood Mononuclear Cell
10%
Interleukin 1
9%
Interleukin 8
9%
Cancer Cell
9%
Airway Smooth Muscle Cell
9%
Chemokine
9%
Myeloid-Derived Suppressor Cell
8%
Proteomics
8%
Immune Response
8%
Immunotherapy
8%
Upregulation
7%
Morbidity
7%
Interleukin 6
7%
In Vitro
7%
Tyrosine
7%
Gene Expression
6%
Programmed Death 1 Ligand 1
6%
Heavy Chain
6%
Epithelium
6%
Eosinophil
6%
Tumor Necrosis Factor
6%
Immunocompetent Cell
6%
Pulmonary Inflammation
6%
Interferon Type I
6%
Programmed Cell Death
6%
Smooth Muscle
5%
Oxidative Stress
5%
Cell Migration
5%
Forced Expiratory Volume
5%
Signal Transduction
5%
Breathing
5%
CD14
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
COVID-19
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
69%
Lung Cancer
32%
Non Small Cell Lung Cancer
27%
Inflammation
26%
Epidermal Growth Factor Receptor
26%
Malignant Neoplasm
24%
Neoplasm
20%
Asthma
16%
Pneumonia
13%
Immunotherapy
11%
Chemotherapy Regimens
10%
Emphysema
10%
Biological Marker
9%
Cohort Study
9%
Sleep Disordered Breathing
8%
Influenza
8%
Vaccination
8%
Lung Adenocarcinoma
8%
Diseases
8%
Adverse Event
8%
Osimertinib
7%
Protein Tyrosine Kinase Inhibitor
7%
Epidermal Growth Factor Receptor Kinase Inhibitor
6%
Corticosteroid
6%
Cisplatin
5%
Tumor Growth
5%
Pleura Effusion
5%
